CA 19-9-expression of a splenic cyst;CA19-9-ERHOHUNG DURCH EINE MILZZYSTE: EINE SELTENE DIFFERENTIALDIAGNOSE

Zentralblatt fur Chirurgie

Volumn 123, Issue 7, 1998, Pages 855-857

  Decker, D ^a   Bollmann, R ^b   Hirner, A ^a   Stratmann, H ^a  

^a UNIVERSITY OF BONN   (Germany)

^b Institut fur Pathologie   (Germany)

Author keywords

CA19 9 expression; Splenic cyst

Indexed keywords

CA 19-9 ANTIGEN; TUMOR MARKER;

ADULT; ARTICLE; FEMALE; HUMAN; SPLEEN CYST; BLOOD; CASE REPORT; CYST; DIFFERENTIAL DIAGNOSIS; PATHOLOGY; SPLEEN; SPLEEN DISEASE; SPLENECTOMY;

ADULT; CA-19-9 ANTIGEN; CYSTS; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; SPLEEN; SPLENECTOMY; SPLENIC DISEASES; TUMOR MARKERS, BIOLOGICAL;

EID: 0031604014     PISSN: 0044409X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Alvarez JA, Marin J, Jover JM, Fernandez R, Fradejas J, Moreno M (1995) Sensitivity of monoclonal antibodies to carcinoembryonic antigen, tissue polypeptide antigen, alpha-fetoprotein, carbohydrate antigen 50, and carbohydrate antigen CA19-9 in the diagnosis of colorectal adenocarcinoma, Dis Colon Rectum 38: 535-542
2. Banfi G, Bravi S, Ardemagni A, Zerbi A (1996) CA19-9, CA242 and CEA in the diagnosis and follow-up of pancreatic cancer. Int J Biol Markers 11: 77-81.
3. Borras G, Molina R, Xercavanis J, Ballesta A, Iglesias J (1995) Tumor antigens CA19 9, CA125, and CEA in carcinoma of the uterine cervix. Gynecol Oncol 57 205-211
4. Elit L, Aylward B (1989) Splenic cyst carcinoma presenting in pregnancy. Am J Hematol 32: 57-60
5. Griga T, May B (1993) Alkoholtoxische akute intrahepatische Cholestase mit reversibler Erhöhung des Tumormarkers CA19-9 bei chronischer Alkoholhepatitis. Z Gastroenterol 31 Suppl 2: 62-63
6. Ishii H, Okada S, Sato T, Wakasugi H, Saisho H, Furuse J, Ishikawa O, Yokoyama S (1997) CA19-9 in evaluating the response to chemotherapy in advanced pancreatic cancer 44: 279-283
7. 6a. Klee F E, Osswald B R, Wysocki St (1996) Die Milzzyste - klassischer "Nebenbefund"? Zentralblatt für Chirurgie 121: 805-816
8. Koprowski H, Steplewski Z, Mitchell K, Herlyn M, Herlyn D, Fuhrer P (1979) Colorectal carcinoma antigens detected by hybridoma antibodies. Somat Cell Genet 5: 957-72.
9. Krischler R (1996) CA19-9 and helicobacter pylori. Dtsch Med Wochenschr 121: 887
10. Nakayama T, Watanabe M, Teramoto T, Kitajima M (1997) Slope analysis of CA19-9 and CEA for predicting recurrence in colorectal cancer patients. Anticancer Res 17: 1379-1382
11. Pleskow DK, Berger HJ, Gyves J, Allen E, Me Lean A, Podolsky DK (1989) Evaluation of a serologic marker. CA19-9. in the diagnosis of pancreatic cancer. Ann Int Med 110: 704-709
12. Safi F, Schlosser W, Falkenrecht S, Beger HG (1996) CA19-9 serum course and prognosis of pancreatic cancer. Int J Pancreatol 20: 153-161
13. Steinberg, WM, Gelfand R, Andersen KK, Glenn J, Kurtzmann SH, Sindelar WF, Toskes PP (1986) Comparison of the sensitifity and specificity of the CA19-9 and carcinoembryonic antigen assays in detecting cancer of the pancreas. Gastroenterology 90: 343-349
14. Tolliver BA, O'Brian BL (1997) Elevated tumor associated antigen CA19-9 in a patient with an enlarged pancreas: does it always imply malignancy? South Med J 90: 89-90
15. Tusuruta T, Ogawa A, Ishii K, Ikado S (1997) CA19-9: a possible serum marker for embryonal carcinoma. Urol Int 58: 20-24
16. Walz MK, Metz KA, Eigler FW (1991) Milzzysten. Ihre Morphologie, Diagnose und Therapie. Dtsch Med Wochenschr 116: 1377-1383